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Introduction
During brain development, neural precursor cells differentiate
into various neuronal subtypes with distinct cellular and
physiological properties. Dopamine-secreting (DA) neurons
represent one of the major neuronal subtypes in the CNS. A
major population of DA neurons resides in the midbrain, and
these cells are known to play crucial roles in the control of
motor and reward behaviors as well as other cognitive functions
(Graybiel et al., 1994; Berke and Hyman, 2000; Nieoullon,
2002). Consistently, dysfunction of midbrain DA neurons is
strongly correlated with the development of Parkinson’s
disease, schizophrenia and drug addiction. Despite the clinical
significance of the midbrain DA system, our knowledge of DA
neuronal development in the midbrain is still limited.
Nurr1 is an orphan nuclear receptor-type transcription factor
whose onset of expression in the developing rodent midbrain
precedes that of the DA neuronal phenotype, as examined by
tyrosine hydroxylase (TH) induction, the rate-limiting enzyme
for DA biosynthesis (Zetterstrom et al., 1996). Gene-targeting
experiments have clearly demonstrated the specific and
crucial requirement of Nurr1 in DA neuronal development
(Zetterstrom et al., 1997; Saucedo-Cardenas et al., 1998;
Castillo et al., 1998). Gain-of-function studies in mouse
embryonic stem cells (Chung et al., 2002; Kim et al., 2002;
Sonntag et al., 2004) and rat nestin-positive neural precursor
cells (Kim, J. Y. et al., 2003; Sakurada et al., 1999) have
demonstrated that Nurr1 could prominently induce the DA
phenotype. However, it is probable that additional factors are
The steroid receptor-type transcription factor Nurr1 has a
crucial role in the development of the mesencephalic
dopamine (DA) neurons. Although ectopic expression of
Nurr1 in cultured neural precursor cells is sufficient in
establishing the DA phenotype, Nurr1-induced DA cells are
morphologically and functionally immature, suggesting
the necessity of additional factor(s) for full neuronal
differentiation. In this study, we demonstrate that
neurogenic basic helix-loop-helix (bHLH) factors Mash1,
neurogenins (Ngns) and NeuroD play contrasting roles in
Nurr1-induced DA neuronal differentiation. Mash1, but
not Ngn2, spatially and temporally colocalized with
aldehyde dehydrogenase 2 (AHD2), a specific midbrain DA
neuronal progenitor marker, in the early embryonic ventral
mesencephalon. Forced expression of Mash1 caused
immature Nurr1-induced DA cells to differentiate into
mature and functional DA neurons as judged by
electrophysiological characteristics, release of DA, and
expression of presynaptic DA neuronal markers. By
contrast, atonal-related bHLHs, represented by Ngn1,
Ngn2 and NeuroD, repressed Nurr1-induced expression of
DA neuronal markers. Domain-swapping experiments with
Mash1 and NeuroD indicated that the helix-loop-helix
domain, responsible for mediating dimerization of bHLH
transcription factors, imparts the distinct effect. Finally,
transient co-transfection of the atonal-related bHLHs with
Nurr1 resulted in an E-box-independent repression of
Nurr1-induced transcriptional activation of a reporter
containing Nurr1-binding element (NL3) as well as a
reporter driven by the native tyrosine hydroxylase gene
promoter. Taken together, these findings suggest that
Mash1 contributes to the generation of DA neurons in
cooperation with Nurr1 in the developing midbrain
whereas atonal-related bHLH genes inhibit the process.
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http://jcs.biologists.org/cgi/content/full/119/11/2310/DC1
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required for differentiation of neural precursor cells
into mature DA neurons. For example, forced
expression of Nurr1 in some cells resulted in either
undifferentiated non-neuronal cells (Sonntag et al.,
2004; Sakurada et al., 1999) or morphologically and
functionally immature DA neurons (Kim, J. Y. et al.,
2003). Therefore, identification of such additional
factors is a prerequisite to further our understanding
of the regulatory cascade underlying the
differentiation of midbrain DA neurons.
The transcription factors belonging to the basic
Helix-Loop-Helix (bHLH) gene family are known
to regulate crucial developmental processes in
various mammalian tissues. Neural bHLH
transcription factors such as Neurogenin 1 (Ngn1),
Ngn2, NeuroD, and Mash1 are expressed in both
the central and the peripheral nervous systems
during development and promote early neuronal
differentiation (for reviews, see Kageyama and
Nakanishi, 1997; Lee, 1997; Bertrand et al., 2002;
Ross et al., 2003). In addition to the generic
neurogenic action, several lines of evidence have
shown that they are also involved in specifying
neuronal subtype identities. In fact, it has been
reported that the achaete-scute homolog Mash1 and
the atonal-related genes Ngn1 and Ngn2 are
expressed in a complementary pattern in the
developing telencephalon, spinal cord and neural
crest, and specify distinct neuronal subtype
identities (Fode et al., 2000; Parras et al., 2002;
Hirsch, 1998; Perez, 1999). It has also been recently
reported that a cooperative or synergistic action of
proneural bHLHs with homeodomain factors
specifies the subtype identity of particular neurons.
For example, Mash1 with Phox2b (Dubreuil et al.,
2002; Pattyn et al., 2004), and Ngn2 with LIM-
homeodomain protein (Lee and Pfaff, 2003) specify
the ventral hindbrain and spinal cord motor neurons,
respectively. These findings prompted us to ask if
such combined action between bHLH and Nurr1 is
necessary for a more complete midbrain DA
neuronal differentiation.
In this study, we report that Mash1 and atonal-related bHLH
factors exert contrasting effects on Nurr1-induced DA neuronal
differentiation. Forced expression of the Mash1 protein, whose
expression is seen in early DA neuronal progenitor cells in the
developing mesencephalon, promoted differentiation of
immature Nurr1-induced DA cells toward mature and
functional DA neurons with pre-synaptic DA neuronal
markers. By contrast, atonal-related Ngn1, Ngn2 and NeuroD
markedly repressed Nurr1-induced acquisition of DA
phenotypes. These findings provide the first evidence for the
specific and discrete roles of bHLH transcription factors in the
development of midbrain DA neurons.
Results
Expression patterns of Mash1 and Ngn2 in the
developing ventral midbrain
We first examined the expression patterns of Mash1 and Ngn2
proteins in the ventral domain of rat embryonic midbrain where
DA neurons develop between embryonic days 11-13 (E11-
E13). Mash1 expression was already detectable throughout the
ventral mesencephalon by E11 and E12 (Fig. 1B-D). Aldehyde
dehydrogenase 2 (AHD2), a specific marker for committed
midbrain DA neuronal progenitor cells colocalizing with Nurr1
mRNA in the early ventral mesencephalon (Wallen et al.,
1999), showed an overlap with Mash1. Specifically, a part of
the Mash1-expressing domain in the more ventral part of
the neural tube containing the floor plate showed AHD2
expression (Fig. 1B). At the cellular level, a major
subpopulation of AHD2-positive DA neuronal progenitor cells
also expressed Mash1 at this stage (Fig. 1B-D). Cells
immunoreactive to TH, one of the terminal DA neuronal
markers, were not detected in the E11-E12 mesencephalons.
TH expression begins to appear at E13 and is restricted to the
cells with differentiated neuronal morphology in the mantle
area of the ventral mesencephalic neural tube (Fig. 1E,F).
Mash1 expression was restricted to the ventricular zone of the
TH-expressing domain in the E13 ventral mesencephalon. This
result is consistent with the previous finding that TH expression
is always external to the proliferative zone marked by Mash1
Fig. 1. Expression of Mash1 and Ngn2 in the developing ventral midbrain.
(A) Embryonic brains were cryosectioned along the red (B-D,G-H) and blue
(E,F) lines, and the immunohistochemical images were taken from the areas in
red (B-D,G-H) and blue (E,F) boxes with confocal microscopy.
(B-D) Localization of Mash1 expression in AHD2-positive DA progenitor cells
in the ventral midbrains at E11 (B,C) and E12 (D). The boxed area of B is
magnified in C. Panel C shows micrographs of the z-stacked confocal picture
along the y-axis (right) and the x-axis (upper). (E,F) Expression patterns of
Mash1 and TH in the E13 ventral midbrain. Note that TH expression is confined
to the mantle region in the ventral midbrain at E13, whereas Mash1 is expressed
in the proliferating ventricular region. Panel F is a higher magnification image
of the white boxed area in E. The expression pattern of Ngn2 in the embryonic
ventral midbrain is shown in panels G-I. Ngn2 expression is not detected in the
ventral midbrain at E12 (G). Inset, Ngn2 expression in the diencephalic area at
E12 (positive control). Ngn2-expressing cells are detected in the ventral
midbrain at E13 (H,I) and a subpopulation of AHD2-positive cells co-express
Ngn2 (I). Bars, 10 m.
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expression in the basal ganglia (Marin et al., 2005). By
contrast, Ngn2 expression was barely detected in the
mesencephalon of embryos at E11-12 (Fig. 1G), but observed
in the ventral domain of E13 midbrain (Fig. 1H,I). In the
ventricular zone of E13 ventral midbrain, Ngn2-positive cells
were intermingled with Mash1-positive cells (Fig. 1H), and
subpopulations of AHD2-positive cells expressed Mash1 or
Ngn2 (Fig. 1I). The similar overlapping pattern of the Mash1
and Ngn2 localizations has been demonstrated in dorsal spinal
cord interneurons (Helms et al., 2005).
Mash1 induces neuronal differentiation of Nurr1-induced
TH cells
We have previously demonstrated that Nurr1 sufficiently
induces the acquisition of DA neuron phenotype in the cultured
neural precursor cells isolated from rat embryonic brains (Kim,
J. Y. et al., 2003). This result suggests that experimental
systems using the neural precursor cell cultures could be used
to investigate the midbrain DA neuron development. The
above regional and chronological patterns of Mash1 protein
expression suggest a specific role of Mash1 in the development
of the midbrain DA neurons. Thus, we examined the effect
of co-expressing Mash1 with Nurr1 in embryonic neural
precursor cells compared with cells expressing Nurr1 only. The
retroviral vector system showed a consistent transduction
efficiency of >90% for all the constructs as examined by
immunocytochemical analysis of transgene expression
(supplementary material Fig. S1). Basal expression of Mash1
was marginal in the naive precursors when analyzed by both
immunocytochemistry and RT-PCR, and was greatly
upregulated by retroviral transduction (supplementary material
Fig. S1). Forced expression of Mash1 resulted in extensive
neurite outgrowth from Nurr1-induced TH-positive cells
(17.9±11.1 M versus 294.8±101.7 M in the cultures for
cortical precursor cells, Fig. 2A-C) without significant
alterations in the number of cells positive for TH (44.5±14.4%
versus 40.1±14.8%; n=20, P=0.13) and TH protein expression
(Fig. 2D). MAP2, a late neuronal marker, was expressed in
50.3±8.6% of TH-positive cells in the cultures transduced with
Nurr1 and Mash1 whereas only 11.0±11.7% of TH cells were
positive to MAP2 in the control cultures transduced with Nurr1
and LacZ (Fig. 2E-G). Furthermore, expression of mRNAs
encoding presynaptic marker proteins (i.e. synaptophysin and
synapsin) and related to growth cone formation (GAP43) was
significantly upregulated by Mash1 (Fig. 2H). The effects of
Mash1 in the maturation of Nurr1-DA cells were similarly
observed in the precursor cells isolated from other brain
regions tested, such as the lateral ganglionic eminences (LGEs)
and ventral midbrain at E13 and E14 (supplementary material
Fig. S2 and data not shown). The following data were obtained
in the cultures for E14 cortical precursor cells unless noted.
We next evaluated mature DA neuronal functions of the
cells transduced with Nurr1 along with Mash1 or LacZ
by estimating DA release, specific DA uptake, and
electrophysiological properties assessed by single-cell
recordings. HPLC analysis demonstrated that DA levels in the
medium conditioned for 24 hours was more than ten times
greater in the Nurr1 and Mash1-transduced cultures
(359.4±32.4 pg/ml of medium), compared with those
transduced with Nurr1 and LacZ (34.7±8.5 pg/ml). An
important functional aspect of mature presynaptic DA neurons
Journal of Cell Science 119 (11)
Fig. 2. Mash1-induced neuronal differentiation of Nurr1-TH cells.
Mash1 or LacZ (control) was co-expressed with Nurr1 in the
precursor cells isolated from rat embryonic cortices using a retroviral
vector system. Differentiation of the precursors was induced and
immunocytochemical, immunoblot and RT-PCR analyses were
performed at day 3 (A-D,H) and at day 15 (E-G) of differentiation.
(A,B) Representative images of TH-immunoreactive cells in the
cultures transduced with Nurr1 and LacZ (A) and Nurr1 and Mash1
(B) at day 3 of in vitro differentiation. Insets, DAPI nuclear staining
of the same field. (C) Morphometric analyses to compare the
dendritic lengths of Nurr1-TH cells in the control and Mash1-
transduced cultures. Box and bar in the graph C represent mean and
s.e.m. of total dendritic lengths, respectively. (D) Western blot
analyses combined with the findings in Fig. 5R,S demonstrate that
Mash1 increased expression of generic neuronal marker TuJ1,
without any effect on the Nurr1-induced TH expression.
(E-G) Localization of the mature neuronal marker MAP2 in Nurr1-
induced TH+ cells. Representative images of MAP2 and TH
immunocytochemistry of control (E) and Mash1-transduced (F)
cultures at in vitro differentiation day 15. Insets, DAPI nuclear
staining of the same field. (G) Percentages of double-immunoreactive
cells for TH and MAP2 (TH+/MAP2+) out of total TH+ cells.
(H) Semi-quantitative RT-PCR analyses for the mRNAs specific to
synaptic formation (synaptophysin and synapsin) and growth cone
development (GAP43). *Significantly different from the controls
with P<0.001. Bars, 10 m.
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2313Roles of bHLH in DA neuron differentiation
is the ability to release DA in response to membrane
depolarization. Conditioning cells in the medium only for 15
minutes did not yield detectable levels of DA by HPLC in both
cultures. However, treatment with high potassium (56 mM)
induced DA release from Nurr1-transduced cells in both
groups of cultures. The DA levels evoked by KCl-
depolarization stimuli for 15 minutes were tenfold greater in
the cultures transduced with Nurr1 and Mash1 (1101.7±40.7
pg/ml versus 106.4±15.3 pg/ml).
DAT-mediated high-affinity reuptake of DA transmitter is
another crucial function of mature presynaptic DA neurons. We
could scarcely observe DA uptake in cells transduced with
Nurr1 and LacZ (control, 0.23±0.01 fmol/minute/well). By
contrast, cells transduced with Nurr1 and Mash1 displayed an
avid DA uptake (2.90±0.61 fmol/minute/well, Fig. 3B).
Electrophysiological properties of Nurr1-expressing cells
were examined in the differentiated cultures transduced with
Nurr1 and Mash1. Individual Nurr1-expressing cells could be
identified based on the expression of GFP from the Nurr1-
IRES-GFP bicistronic expression construct. The Nurr1-GFP-
expressing cells with a differentiated neuronal shape were
chosen for electrophysiological analysis using the conventional
whole-cell recording technique. Recordings in the current-
clamp configuration allowed us to determine the active
membrane characteristics of these cells. Prolonged
depolarizing current injections (Fig. 3C, left panel)
demonstrated the capability to fire fast action potentials. The
cells also exhibited voltage-dependent membrane currents
(Fig. 3C, right panel). Depolarizing voltage steps elicited both
large outward potassium currents and fast inward sodium
currents. These action potential and inward sodium currents
were completely blocked by tetrodotoxin (TTX) treatment (3
M) (Fig. 3D). These results indicate the presence of well-
developed sodium and potassium channels, characteristic of
differentiated neurons. In addition, membrane potential
changes were investigated in cells subjected to hyperpolarizing
current injections. As the intensity of the hyperpolarizing
current was increased, there was a time-dependent reduction in
Fig. 3. Acquisition of presynaptic
neuronal function by Nurr1-induced DA
cells with Mash1. Precursor cells from
E14 cortices were transduced with
Nurr1 and Mash1 (N+M) or Nurr1 and
LacZ (N, control), and the functional
analyses were performed after 10 days
of in vitro differentiation. (A) HPLC
quantification of DA release. The graph
shows DA levels in the medium
conditioned for 24 hours (24 hr
medium) and released by KCl-evoked
depolarization in N2 with 56 mM KCl
for 15 minutes (KCl 15min), n=3.
(B) DA uptake. The graph shows the
specific DA uptake of the cells
transduced with Nurr1 and Mash1 or
Nurr1 and LacZ (n=5 for each value).
Specific DA uptake was calculated by
subtracting non-specific uptake (with
nomifensine) from value without
nomifensine. *Significantly different
from the controls at P<0.001.
(C-E) Electrophysiological properties of
cells differentiated from the precursor
cells transduced with Nurr1 and Mash1.
(C) Typical recordings of
electrophysiological properties of a
differentiated neuron. Left panel,
Current-clamp recordings during
prolonged depolarizing current
injections. Top traces represent current
injections, whereas bottom traces
indicate voltage recordings.
Depolarizing current injections elicited
fast action potentials. Right panel,
voltage-dependent membrane currents.
Depolarizing voltage steps (top traces)
elicited outward K+ currents and fast
inward Na+ currents (bottom traces).
(D) Effect of tetrodotoxin (TTX) on
action potential and voltage-dependent Na+ currents. TTX completely inhibited the action potential evoked by depolarizing current injections.
Inset, Na+ current by depolarizing voltage steps. (E) Current-clamp recordings during prolonged hyperpolarizing current injections. The cells
display the time-dependent anomalous rectification that is a characteristic of midbrain DA neurons after a hyperpolarizing pulse.
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the membrane deflection (Fig. 3E), indicating an anomalous
rectification characteristic of mesolimbic (Rayport et al., 1992)
and nigrostriatal (Rohrbacher et al., 2000) DA neurons. Such
rectification, however, could hardly be observed in the cells
transduced with Nurr1 alone (or Nurr1 and LacZ), although the
other electrophysiological properties described above could be
detected in the Nurr1-transduced cells with well-differentiated
neuronal shape.
Inhibitory role of atonal related bHLHs in Nurr1-induced
expression of DA phenotype
We carried out similar experiments with atonal-related bHLH
genes, Ngn1, Ngn2 and neuroD. To our surprise, co-expression
Journal of Cell Science 119 (11)
of each of these genes with Nurr1 dramatically repressed
Nurr1-induced TH expression by 79-98%, as estimated by the
number of cells positive for TH (Fig. 4A-E). Consistent with
this finding, our immunoblotting analysis showed that TH
protein levels were also significantly downregulated (Fig. 4F).
This is in clear contrast to cells infected with Mash1-
expressing virus (Fig. 2D), which showed no changes in TH
expression. Importantly, overexpression of Ngn1, Ngn2 and
NeuroD markedly diminished Nurr1-induced expression of
mRNAs specific to DA phenotype such as DAT, AADC, and
VMAT2 as well as TH (Fig. 4G), suggesting an inhibitory
action of the atonal bHLH proteins in DA phenotype
expression. The inhibitory roles of neurogenins and NeuroD
were also observed in the cultures of different neural precursors
tested, such as those isolated from the cortices, LGEs and
ventral midbrains at either E13 or E14 (supplementary material
Fig. S2 and data not shown).
Helix-Loop-Helix domains are responsible for the
specificity of the bHLH effects in Nurr1-induced DA
differentiation
Basic helix-loop-helix (bHLH) transcriptional factors bind to
DNA via the basic regions of bHLH. The HLH portion is
responsible for the protein-protein interaction between bHLH
proteins or with other proteins (Ma et al., 1994; Ellenberger et
al., 1994). Mutant derivatives of atonal-related bHLH genes,
Ngn1/AQ, NeuroD/AQ, and NeuroD/G whose DNA binding
capacity is abolished, did not display the inhibitory effect on
the TH expression seen with wild-type genes (Fig. 5A-H),
suggesting that DNA binding is required for the inhibitory
activity of the atonal-related bHLH proteins. These mutations
also resulted in the loss of general neuronal differentiation
activity as estimated by TuJ1 expression (Fig. 5H), consistent
with the notion that bHLH-mediated neurogenesis occurs
via direct binding to target promoters and promoting
transcriptional initiation.
To identify the important domain of the bHLH factors that
impart distinct activities in Nurr1-induced DA differentiation,
we generated a series of chimeric proteins by interchanging
HLH domains between NeuroD and Mash1 and between
NeuroD and muscle-specific bHLH factor MyoD. Forced
expression of MyoD, a skeletal-muscle-specific myogenic
bHLH gene, in the Nurr1-infected cultures did not alter the
proportion of TH+ cells, compared with the control cultures
transduced with Nurr1 and LacZ retroviral vectors, despite the
fact that total cell number was reduced in the MyoD-infected
culture, presumably by decreased cell proliferation and/or
viability. A reduction in the number of TH+ cells and in the
level of TH protein, comparable to levels seen with the wild-
type NeuroD, was observed by introducing chimeric protein
MD, which is composed of Mash1 basic region and NeuroD
HLH domain (Fig. 5J-S). Such data indicate that it is the HLH
domain of NeuroD which is responsible for the inhibitory
activity of NeuroD. Consistently, the substitution of the basic
region in NeuroD with that of MyoD (in the chimera YD) did
not affect NeuroD-induced inhibition of TH expression. We
also examined the effect of DM which contains the basic region
of NeuroD and the HLH domain of Mash1. In the cultures
transduced with DM-bHLH, no significant alterations in TH+
cell number or in TH protein level was observed. Furthermore,
as seen with the wild-type Mash1, enhanced levels of neurite
Fig. 4. Inhibitory activity of the atonal-related bHLH proteins on
Nurr1-induced expression of DA neuronal phenotype. The cortical
precursor cells, at day 3 of in vitro expansion, were transduced with
Nurr1 plus Ngn1, Ngn2, NeuroD or LacZ (control) using retroviral
infection. After 3 days of differentiation, the cultures were subjected
to immunocytochemical (A-E), immunoblot analyses (F) for TH and
RT-PCR analyses (G) for TH, AADC (DA synthesis), VMAT2 (DA
storage) and DAT (DA uptake). (A-D) Representative images of
TH/TuJ1 immunocytochemistry on the cells transduced with LacZ
(A), Ngn1 (B), Ngn2 (C), and NeuroD (D) along with Nurr1. Note
that TH+ cell numbers were reduced by the bHLH co-expression,
with increases of TuJ1+ neurons. Insets, DAPI nuclear staining of the
same fields. The graph in E represents percentage of TH+ cells out of
total (DAPI+) cells. *Significantly different from the control at
P<0.001. Bars, 10 m.
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outgrowths from Nurr1-induced TH cells were observed by
forced expression of the chimera DM (data not shown). The
chimera DY showed an indistinguishable effect from that of
wild-type MyoD. Taken together, these results indicate that
although DNA binding through the basic region is a
prerequisite for their respective activities, HLH domains, but
not the basic domains, of Mash1 and NeuroD contain the
information that specifies distinct roles of each bHLH gene in
Nurr1-induced DA differentiation.
Inhibitory activity of Ngn1 in TH expression is not
attributable to either cell cycle arrest or inhibition of
JAK/STAT signal
The inhibitory effects of Ngn1, Ngn2 and NeuroD were
qualitatively and quantitatively similar although NeuroD
was slightly less effective than neurogenins. The subsequent
experiments were thus mostly carried out with Ngn1. We
confirmed that the effect of Ngn1 expression was intracellular
autonomous in nature. The degree of reduction of TH+ cells was
the same whether the cells were transduced with bicistronic
Nurr1-IRES-Ngn1 construct or with separate Ngn1 and Nurr1
constructs. Neither co-culture with Ngn1-infected cells nor
treatment with conditioned medium prepared from Ngn1-
infected cultures elicited an inhibitory effect on the Nurr1-
induced TH expression (data not shown). These findings confirm
the intracellular cell-autonomous mechanism of Ngn1 activity.
TH+ cell number in Nurr1 and Ngn1-transduced cultures was
significantly less than the cultures transduced with Nurr1 alone
from 1 day after infection (data not shown), suggesting that the
inhibitory action of Ngn1 is not due to a delayed response of
persistent Ngn1 overexpression. Ngn1 infection 1 day before
Nurr1 infection was also effective in inhibiting Nurr1-induced
TH expression. By contrast, when cultures were infected with
Ngn1 1 day after Nurr1 infection, there was no clear decrease
in TH+ cell numbers (data not shown). It has been reported that
Nurr1-induced TH expression in the C17.2 neural stem cell line
was observed only in cells with a high proliferation capacity
(Wagner et al., 1999). Since proneural bHLH-induced neuronal
differentiation is concomitant with the cell-cycle withdrawal,
the inhibitory effect of Ngn1 in DA differentiation might be a
consequence of neurogenin-induced cell-cycle arrest. To test
this possibility, we used the FGF receptor blocker SU5402
(Mohammadi et al., 1997) and the MAPK inhibitor PD98059
(Alessi et al., 1995), which are inhibitors of bFGF signaling
Fig. 5. Essential structural
components of Ngn1 and NeuroD
required for the inhibitory actions on
Nurr1-induced TH expression.
(A-H) Effect of the abolishment of
DNA-binding capacity of Ngn1 and
NeuroD. Each of the wild types and
the DNA-binding mutants of Ngn1
and NeuroD was introduced into
Nurr1-transduced precursors by co-
infection as described in the Materials
and Methods, and TH+ cell numbers
and TH protein levels were
determined at day 3 of differentiation
using immunocytochemical (A-G)
and western blot analyses (H),
respectively. Note that the
abolishment of the DNA-binding
capacity in Ngn1 and NeuroD
abrogates not only their generic
neurogenic activities (TuJ1 protein
level in H), but also the inhibitory
activity on Nurr1 and TH expression.
(I) Schematic diagrams of the
chimeric proteins of NeuroD (D) and
Mash1 (M) or NeuroD and MyoD (Y)
used to identify the domains for the
differential roles of Mash1 (or MyoD)
and NeuroD. Co-transduction of each
of the chimeric proteins with Nurr1
was carried out as described above,
and the effects of the chimeric bHLHs
on Nurr1-TH expression were
determined at day 3 of differentiation
by immunochemical (J-R) and
immunoblot (S) analyses.
(J-S) Analyses of the chimeric proteins reveal that the HLH domains are responsible for the differentiation actions of Mash1 and NeuroD. Note
that the effects of the chimera YD and MD, which hold NeuroD HLH domain, on Nurr1-induced TH+ cell numbers and TH protein levels are
not distinguishable from those of wild-type NeuroD, whereas the inhibitory activity of NeuroD is abolished by substituting the HLH domain
with that of Mash1 or MyoD (in chimera DM or DY). Graphs G and R represent the mean percentage (± s.e.m.) of TH+ cells out of total DAPI+
cells. *Significantly different from the controls at P<0.001. Bars, 10 m.
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
2316
that is required for neural precursor cell proliferation. The
treatment of these bFGF signal blockers indeed resulted in a
decrease of cell proliferation, as estimated by the BrdU+ cells
(supplementary material Fig. S3B). Importantly, although the
inhibitory effect of SU5402 on the cell proliferation was much
greater than that of Ngn1 (%BrdU+ cells of total cells;
0.6±0.2% in Ngn1-infected versus 10.0±0.8% in SU5402-
treated cultures; n=20, P<0.01), TH+ cell number, compared
with untreated control cultures, only slightly decreased in the
cultures treated with SU5402. The effect of Ngn1 on the
decrease in the number of TH+ cells was much greater than that
of SU5402 (TH+/Nurr1+ cells; 3.9±0.6% in Ngn1-infected
versus 0.9±0.3% in SU5402-treated cultures; n=20, P<0.01)
(supplementary material Fig. S3C). This result indicates that
Ngn1-mediated repression of TH expression is not attributable
to the reduced cell proliferation.
Ngn1 inhibits astrocytic differentiation by blocking the
activation of STAT transcription factor that is necessary for
gliogenesis and by sequestering CBP-p300, which forms
an active complex with Smad1, away from astrocyte
differentiation genes (Sun et al., 2001). Thus, we tested
whether Ngn1-mediated inhibitory activities on gliogenesis
and DA differentiation share common mechanisms. The JAK-
STAT pathway can be activated and inhibited by treatment with
LIF (Fukada et al., 1996) and AG490 (Gazit et al., 1991)
respectively. Neither the activation of the STAT signaling by
LIF nor the inhibition by AG 490 had any influence on Nurr1-
induced TH+ cell yields (data not shown). We also asked if
Nurr1 requires CBP-p300 for the transactivation of TH gene
and the reduced availability of CBP-p300 by Ngn1-mediated
sequestration is the underlying mechanism for Ngn1-induced
inhibition of TH expression. If this were the case, the inhibitory
activity would be restored by introducing extra CBP-p300.
However, co-expression of CBP-p300 did not restore the
inhibitory activity of Ngn1 (data not shown). Taken together,
these data indicate that Ngn1-mediated regulation of STAT and
CBP-p300 is not likely to be responsible for the repression of
TH expression in the Ngn1-transduced cultures.
Atonal-related bHLH factors repress Nurr1-induced
transactivation of TH promoter activity
We noted that both protein and mRNA levels of TH were
markedly suppressed by Ngn1 (Fig. 4G), suggesting that Ngn1
may act at the transcriptional level in TH gene regulation by
Nurr1. Although the TH promoter contains multiple sequence
motifs homologous to the Nurr1-binding motif, only NL3,
positioned from –872 to –865 of the transcription initiation
site, showed a high affinity to Nurr1 (Kim, K. S. et al., 2003).
Forced expression of Nurr1 in the cortical precursor cells
markedly increased reporter gene expression driven by the
native TH promoter (>1000-fold increase compared with the
control cultures transfected with empty pEF1 plasmid).
Interestingly, co-expression of Ngn1, 2 or NeuroD with Nurr1
resulted in a potent repression of Nurr1-induced activation of
the promoter (% activities relative to Nurr1 and LacZ control:
5.1±0.8, 5.7±0.4 and 10.7±3.8 in the cultures co-tranduced
with Ngn1, Ngn2, and NeuroD, respectively; Fig. 6A). By
contrast, no significant change in TH promoter activity was
observed by Mash1 co-expression. The existence of a
consensus binding sequence (E-box; CANNTG) for bHLH
proteins within the tested TH promoter (from –186 to –181)
Journal of Cell Science 119 (11)
suggested that the inhibitory role of the atonal-related bHLHs
might be mediated by binding to this E-box. However, Nurr1-
induced increase of NL3-driven reporter activity, without the
E-box, was similarly blocked by all of the atonal-related
bHLHs tested (Fig. 6B), suggesting that the binding of the
bHLHs to the E-box is not necessary for the inhibitory effect.
Similar to the findings of the effect on TH+ cell yield
(Fig. 5), DNA-binding mutants Ngn1/AQ, NeuroD/AQ and
NeuroD/G did not elicit inhibitory activities on the Nurr1-
induced transcription activation in the TH reporter assay (Fig.
6A). Substituting the HLH region of NeuroD with that of
Mash1 (chimera DM) also abolished the repressive activity of
NeuroD on the Nurr1-induced transactivation, whereas Nurr1-
induced activation of TH promoter and NL3 reporter activities
were significantly repressed by co-expressing the chimera MD
which contains the NeuroD HLH region. Taken together, these
results indicate that atonal related bHLH genes repress the TH
gene by binding to DNA as well as to their specific
transcriptional co-regulator. Furthermore, the fact that the E-
box within TH is not required for their inhibitory effect raises
the possibility that inhibition may be indirect (see Discussion).
Fig. 6. Atonal-related bHLHs repress Nurr1-induced transactivation
of TH promoter activity. Promoter assays using the reporter vectors
driven by TH6.0 (A) and NL3 (B) were performed as described in
Materials and Methods. The data represent mean percentages (±
s.e.m.) of luciferase activities relative to that of the control (sample
transfected with pEF1-Nurr1 plus pEF1-EGFP). Titles of the
treatments including the bHLH mutants and chimeras were
abbreviated as shown in Fig. 5. Luciferase activity was determined at
day 2 of post-transfection and normalized to the activity of the -
galactosidase. *Significantly different from the control at P<0.001 in
the duplicates of three independent experiments.
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Discussion
An emerging theme in developmental neurobiology is that
combinatorial actions of different transcription factors are
crucial for the development and specification of subtypes of
neuronal lineages (Goridis and Rohrer, 2002; Shirasaki and
Pfaff, 2002). We have previously demonstrated that Nurr1
overexpression in cultured embryonic cortical precursor cells
induced the expression of the markers specific to DA neurons
including the genes involved in biosynthesis of DA (TH and
AADC) as well as its storage (VMAT2) and uptake (DAT)
(Kim, J. Y. et al., 2003). However, we noted that the resulting
cells could not be qualified as mature DA neurons by
morphological, immunocytochemical or presynaptic-
functional criteria, strongly suggesting the requirement of
additional transcription factor(s). In this report, using the same
embryonic cortical precursor cultures as the model system, we
investigated whether bHLH transcription factors are involved
in the potential combined actions with Nurr1 for differentiation
of precursor cells to mature and functional DA neurons.
Although mammalian atonal-related and achaete-scute
homolog bHLHs share a general neurogenic activity, they play
discrete and non-overlapping roles in the neuronal subtype
specification in certain brain regions and in peripheral ganglia.
Consistent with this established paradigm, we found that there
is a striking difference in the effect of these bHLHs in the
differentiation of midbrain DA neurons induced by Nurr1:
whereas Mash1 facilitates neuronal differentiation of cortical
precursor cells into functional and mature DA neurons in the
presence of Nurr1, the atonal-related bHLHs inhibits the
Nurr1-mediated induction of DA phenotypes.
Mash1 is expressed in the ventral domains of the embryonic
brain and specifies ventral neuronal subtypes such as
GABAergic neurons in the forebrain (Fode et al., 2000; Parras
et al., 2002), brachiofacial- and viscero-motor neurons
(Dubreuil et al., 2002; Pattyn et al., 2004) and serotonergic
neurons (Pattyn et al., 2004) in the hindbrain. Mash1 is also a
determinant for noradrenergic neurons in the locus coeruleus
(Goridis and Brunet, 1999; Pattyn et al., 2000) and sympathetic
neurons in the peripheral ganglia (Hirsh et al., 1998; Lo et al.,
1998; Pattyn et al., 1999; Goridis and Rohrer, 2002). Our new
findings furthermore suggest that Mash1 may also play a
crucial role for midbrain DA neuron development.
In the generation of specific subtypes of neurons, proneural
bHLHs not only play the role of a lineage determinant but also
assume the responsibility of activating subtype-specific genes.
However, because the subtype determination by the bHLHs
occurs in a context-dependent manner in the specific brain
regions, the bHLH proteins usually cooperate with other
region-specific factors such as homeodomain genes for the
neuronal subtype specification. For instance, it has been
demonstrated that Mash1 acts in the sympathetic ganglia in a
combinatorial manner with a determinant of the noradrenergic
phenotype, the homeodomain protein Phox2b, to induce the
expression of genes specific for noradrenergic phenotype
(Hirsh et al., 1998; Lo et al., 1998; Pattyn et al., 1999; Goridis
and Rohrer, 2002). Another example of cooperation between
bHLH and homeodomain factors has been shown in the
specification of motor neuronal fate in the embryonic spinal
cord: Ngn2-NeuroM interacts with LIM-homeodomain factors
to form an active and efficient transcription complex which
then activates transcription of motor-neuron-specific genes
(Lee and Pfaff, 2003). We have shown here that Mash1, but not
neurogenin, is expressed in the ventral domain of early
embryonic midbrain before the appearance of TH+ DA cells
and that the expression of Mash1 is seen in AHD2+ DA
neuronal progenitor cells (Fig. 1). In addition, Mash1 in vitro
leads to neuronal maturation and acquisition of pre-synaptic
functionality in the cells that acquired DA neuronal phenotypes
through Nurr1 activity. These findings suggest an involvement
of Mash1 in the development of midbrain DA neurons.
However, unlike other cases of cooperation involving bHLH
genes, Mash1 is not likely to have a cooperative or synergistic
role with Nurr1 in the DA phenotype specification. This is
because Mash1 does not have an additive or cooperative effect
on the Nurr1-induced expression of DA phenotype genes such
as TH, AADC, VMAT2 and DAT (Fig. 2A,B and data not
shown) or in TH promoter assay (Fig. 6). Mash1-mediated
improvement in DA release and uptake, without induction of
the related gene expression, could be mediated by the role of
Mash1 in the functional maturation of VMAT2 and DAT
proteins, such as in the processes of protein modification and
proper subcellular localization. The mechanisms need to be
clarified in further studies. Furthermore, Mash1 did not activate
the expression of the genes specific to midbrain DA neuronal
markers (Nurr1, Ptx3) or to midbrain development markers
(engrailed-1, Pax-2) (data not shown). Thus, although Mash1
and Nurr1 apparently work together in the midbrain DA
development, they probably play independent roles.
Specifically, Mash1 induces neuronal differentiation and
maturation whereas Nurr1 mediates DA-specific phenotype
expression. A similar mode of non-interactive involvement in
a common developmental pathway has been previously
observed in the generation of neuronal subtypes in the retina.
Mash1 apparently determines only the generic neuronal fate in
the retina without activating subtype-specific genes in a layer
identified and specified by Chx10, a homeodomain gene
(Hatakeyama et al., 2001).
Interestingly, atonal-related bHLH genes display an
inhibitory effect in the Nurr1-induced expression of the genes
specific to DA phenotype. We have ruled out several
mechanistic possibilities of this inhibition, such as Ngn-
mediated inhibition of the JAK/STAT signal, and sequestering
p300-CBP away from participating in transcriptional activation
of the TH gene. Importantly, atonal-related bHLH genes
dramatically repressed the Nurr1-induced transactivation of
TH promoter activity (Fig. 6). The findings obtained from the
TH promoter assays using the DNA-binding mutants and
chimeric proteins of the bHLHs indicated that DNA binding is
absolutely required for the inhibitory roles of the atonal-related
bHLHs and that interaction with specific co-regulator is
likewise necessary. Furthermore, the unique E-box within the
TH promoter does not appear to be functional in the inhibition
by the atonal-related bHLH genes. Thus, the detailed
mechanism still needs to be elucidated. It is possible that a new
cis-element within the TH promoter is specified by a
transcription complex that atonal-related bHLH genes form. It
is also possible that the effect is indirect. In other words, the
bHLH gene may be inducing the expression of another gene
product whose presence leads to the inhibition of TH promoter.
The inhibitory role of neurogenins demonstrated using in
vitro culture systems has certain elements of agreement with
DA neuronal development in vivo. The complementary pattern
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
2318
of Mash1 and Ngn2 expression seen in the telencephalon and
spinal cord is not observed in the embryonic midbrain (Fig.
1H). Rather, Ngn2 expression shows a lag and could not be
detected in the ventral midbrain during the early embryonic
ages (E11 and E12). By E13, when Ngn2 is seen in the
ventricular zone of AHD2-positive domain in the ventral
midbrain (Fig. 1I), a population of cells in the mantle zone are
already TH positive (Fig. 1E,F). The similar expression pattern
and opposite roles of Mash1 and Ngn2 have recently been
demonstrated in the generation of dorsal spinal cord
interneurons: Mash1 is required for the formation of dorsal
interneuron 3 (dI3) and dI5 neurons, whereas Ngn2 acts to limit
the number of these neuronal populations (Helms et al., 2005).
Similarly, the late appearance and inhibitory action of Ngn2 in
the ventral midbrain may imply that the role of Ngn2 in this
region is to confine the number of midbrain DA neurons, which
is consistent with the effect seen in vitro. Further studies could
clarify the significance of the inhibitory actions of the bHLH
proteins in midbrain DA neuronal development in vivo.
In summary, using embryonic neural precursor culture, we
found that neurogenic bHLH factors Mash1, neurogenins and
NeuroD have contrasting roles in Nurr1-induced DA neuronal
differentiation. Mash1 was expressed in midbrain DA neuronal
progenitors and its forced expression caused immature Nurr1-
induced DA cells to differentiate into mature and functional
DA neurons with presynaptic DA neuronal markers. By
contrast, atonal-related bHLHs (Ngn1, Ngn2 and NeuroD)
repressed Nurr1-induced expression of DA neuronal markers.
This new information will be useful not only for our
understanding of transcriptional regulatory cascade underlying
the midbrain DA neuron development, but also for future in
vitro generation of functional DA neurons from stem and/or
progenitor cells for cell therapy of Parkinson’s disease, which
is caused by the loss of midbrain DA neurons.
Materials and Methods
Primary CNS neural precursor cultures
Time-pregnant Sprague-Dawley rats were purchased from KOATECH (Seoul,
Korea). Embryonic CNS tissues were dissected from the cortex, lateral ganglionic
eminence (LGE, anlage of striatum), and ventral midbrain of rat embryos at
embryonic day 13 (E13) or E14 and mechanically dissociated in Ca2+/Mg2+-free
Hank’s balanced salt solution (CMF-HBSS; Invitrogen, Carlsbad, CA). Cells were
plated at 8000 cells/cm2 on 10 cm tissue culture dishes (Corning, Corning, NY) pre-
coated with poly-L-ornithine (15 g/ml, Sigma, St Louis, MO) at 37°C overnight
followed by fibronectin (1 g/ml, Sigma) for at least 2 hours. Neural precursor cells
were allowed to proliferate in the presence of 20 ng/ml basic fibroblast growth factor
(bFGF; R&D Systems, Minneapolis, MN) in serum-free medium (N2) (Johe et al.,
1996) for 4-6 days. The bFGF-expanded precursor cells were dissociated by
incubation for 1 hour with CMF-HBSS followed by mechanical pipetting, re-plated
onto freshly coated coverslips (12 mm diameter; Carolina Biological Supply
Company, Burlington, NC) or culture plates, and grown in N2 medium with bFGF.
When cultures were 50-60% confluent, cells were subjected to retroviral infection
as described below. Cell differentiation was induced by withdrawal of bFGF.
Cultures were maintained at 37°C in 5% CO2, media changes were carried out every
other day, and bFGF was supplemented daily. In certain experiments, leukemia
inhibitory factor (20 ng/ml, ESGRO®, Chemicon, Temecula, CA) and AG490 (15
M, Calbiochem, San Diego, CA) were added to cultures.
Retroviral vector construction and virus production
The retroviral vectors expressing Nurr1 were constructed by inserting Nurr1 cDNA
into the monocistronic retroviral vector pCL or into the bicistronic vector pIRES-
LacZ-CL or pIRES-eGFP upstream to IRES element as described previously
(pNurr1-IRES-LacZ or pNurr1-IRES-eGFP) (Kim, J. Y. et al., 2003). The rat
Mash1, mouse Ngn1, mouse Ngn2 and hamster NeuroD cDNAs were amplified
using high fidelity Taq polymerase® (Invitrogen) and cloned into pGEM T-Easy®
(Promega, Madison, WI). pCL retroviral vectors harboring these genes were
generated by inserting NdeI and SalI fragments derived from each pGEM T-Easy
intermediate. The vectors pNurr1-IRES-Mash1, pNurr1-IRES-Ngn1, pNurr1-IRES-
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Ngn2 and pNurr1-IRES-NeuroD, designed for co-expressing each of the bHLH
genes with Nurr1, were constructed by replacing LacZ of pNurr1-IRES-LacZ with
each of the bHLH cDNAs. The two DNA-binding mutants, Ngn1/AQ (Sun et al.,
2001) and NeuroD/AQ (modeled after Ngn1AQ), were generated by changing two
amino acids NR, located in the basic region of the bHLH proteins and crucial for
DNA binding, into AQ using the QuickChange® II XL site-directed mutagenesis kit
(Stratagene, La Jolla, CA) system. For the generation of another NeuroD DNA-
binding mutant NeuroD/G, amino acid R of the basic region was substituted with
G in a similar fashion to the previously described mutant for Mash1/G (Ellenberger
et al., 1994; Ma et al., 1994; Nakada et al., 2004). The basic region of NeuroD was
fused to the HLH domains of Mash1 (M) and MyoD (Y), to generate the chimeric
proteins DM and DY, respectively. Similarly, the chimeras MD and YD were
generated by fusing the basic regions of Mash1 or MyoD (by respectively fusing
the basic regions of Mash1 and MyoD) to the NeuroD HLH domain. Conventional
methods for PCR amplification, digestion with restriction enzymes and ligation
reactions were used for the production of the chimeras. All the constructs generated
were sequence verified before use. The precise sequences of the bHLH regions used
for the chimeric proteins and mutants are shown in Fig. 5I. The retroviral vectors
were introduced into the retrovirus packaging cell line 293gpg (Ory et al., 1996) by
transient transfection with Lipofectamine® (Invitrogen). After 72 hours, the
supernatants were harvested and used for infecting cultured precursor cells as
described above. Cells were incubated with virus in the presence of polybrene (1
g/ml) for 2 hours. For co-expression of the bHLHs or the bHLH mutants with
Nurr1, each of the viruses of the monocistronic pCL constructs [(pCL-Mash1, pCL-
Ngn1, pCL-Ngn2, pCL-NeuroD, bHLH mutant constructs, and pCL-LacZ (control)]
was mixed with that of pCL-Nurr1 1:1 (v:v) and applied to cells for infection. In
certain experiments, viruses of the bicistronic vectors pNurr1-IRES-Mash1, pNurr1-
IRES-Ngn1, pNurr1-IRES-Ngn2, pNurr1-IRES-NeuroD and pNurr1-IRES-LacZ
(control) were used for co-expression. In most cases, differentiation of the infected
precursors was induced in N2 medium 1 day after infection.
Immunostaining of cultured cells and brain slices
Rat embryos at E11-E13 were cut at the level of the isthmus (midbrain-hindbrain
junction). The brain rostral parts were soaked in 4% paraformaldeyde solution
overnight and cryopreserved by sinking in 20% (w/v) sucrose solution. The brain
tissues were subsequently frozen in Tissue-Tek® (Sakura Finetek, Torrance, CA)
solution and sectioned with cryostat at 15 m as shown in Fig. 1A. Cultured cells
or cryosectioned brain slices were fixed in 4% paraformaldehyde/0.15% picric
acid in phosphate-buffered saline (PBS) and were incubated with primary
antibodies overnight at 4°C. The following primary antibodies were used at the
concentrations given: anti rabbit-aldehyde dehydrogenase 2 (AHD2, a kind gift
from G. Duester, Burnham Institute for Medical Research, La Jolla, CA; 1:300),
TH (Pel-Freez, Rogers, AR, 1:250), neuron-specific class III -tubulin (TuJ1,
Covance, Richmond, CA, 1:2000), Nurr1 (Chemicon, 1:100), anti-mouse-Mash1
and Ngn2 (a kind gift from D. J. Anderson, Howard Hughes Medical Institute,
Pasadena, CA; 1:1000 and 1:5, respectively), TH (Sigma, 1:10,000),
Bromodeoxyuridine (BrdU, Accurate Chemical, Westbury, NY, 1:400),
microtubule-associated protein 2 (MAP2, Sigma, 1:500) and GFP (Roche,
Mannheim, Germany, 1:400). Appropriate fluorescence-tagged (Jackson
Immunoresearch Laboratories, West Grove, PA) secondary antibodies were used
for visualization. Cells and tissue sections were mounted in Vectashield® with
DAPI (Vector Laboratories, Burlingame, CA) mounting medium for fluorescence
and photographed using a epifluorescence microscope (Nikon, Melville, NY).
RNA extraction and RT-PCR analysis
Total cellular RNA was prepared using TRI REAGENT® (Molecular Research
Center, Cincinnati, OH) following the manufacturer’s recommendations. For the
synthesis of cDNA, a Superscript kit (Invitrogen) was used. The PCR reactions were
carried out following standard protocols. Optimal MgCl2 concentrations and cycle
numbers for linear amplification range were determined. Primer sequences (forward
and reverse), number of cycles, annealing temperature and product sizes (base pairs)
were as follows: GAPDH (5-GGCATTGCTCTCAATGACAA-3 and 5-AGGG-
CCTCTCTCTTGCTCTC-3, 25 cycles, 60°C, 165 bp); synapsin I (5-CCACCCC-
CACAAGGCCAGCAACA-3 and 5-GGTCCCCCGGCAGCAGCAATGATG-3,
29 cycles, 58°C, 512 bp); synaptophysin (5-TGGTATCCTACCGCATTC-3 and
5-ACTCACCTCATAGCTCC-3, 26 cycles, 58°C, 379 bp), GAP43 (5-AGAAA-
GCAGCCAAGCTGAGGAGG-3 and 5-CAGGAGAGACAGGGTTCAGGTGG-
3, 24 cycles, 58°C, 167 bp), TH (5-TGTCAGAGGAGCCCGAGGTC 3 and
5-CCAAGAGCAGCCCATCAAAG-3, 35 cycles, 60°C, 412 bp); DAT (5-GGA-
CCAATGTTCTTCAGTGGTGGC-3 and 5-GGATCCATGGGAGGTCCATGG-
3, 30 cycles, 58°C, 289 bp); VMAT2 (5-CTTTGGAGTTGGTTTTGC-3 and
5-GCAGTTGTGGTCCATGAG-3, 33 cycles, 55°C, 301 bp); AADC (5-CCT-
ACTGGCTGCTCGGACTAA-3 and 5-GCGTACCAGTGACTCAAACTC-3, 30
cycles, 58°C, 163 bp). Mash1 (5-GGCTCAACTTCAGTGGCTTC-3 and 5-TGG-
AGTAGTTGGGGGAGATG-3, 28 cycles, 55°C, 291 bp); Ngn1 (5-CCAGGAC-
GAAGAGCAGGAA-3 and 5-GGTGAAGTCTTCTGAAGCCGA-3, 35 cycles,
60°C, 468 bp); Ngn2 (5-TTCGTCAAATCTGAGACTCTGG-3 and 5-TGCG-
CGCGACGGGCGACGCT-3, 35 cycles, 59°C, 273 bp); NeuroD (5-CTCAG-
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TTCTCAGGACGAGGA-3 and 5-TAGTTCTTGGCCAAGCGCAG-3, 30 cycles,
60°C, 368 bp). RT-PCR products were analyzed with agarose gel electrophoresis.
Western blot analysis
Cultured cells were lysed in 20 mM Tris-HCl, pH 7.4, 10 mM EDTA, 0.5% Triton
X-100, 1 mM PMSF, 10 g/ml aprotinin, and 10 g/ml leupeptin. Protein
concentration was determined using Bio-Rad Protein Assay® (Bio-Rad, Hercules,
CA). A total of 20 g protein for each sample was run on an 8% SDS
polyacrylamide gel and transferred to a nitrocellulose membrane (Whatman S&S,
Portland, OR). The blot was probed with an anti-mouse-TuJ1 (1:1000), TH
(1:5,000), anti--actin (Abcam, Cambridge, UK, 1:5000) or anti-rabbit Nurr1
(1:100) antibodies, followed by anti-mouse or anti-rabbit IgG conjugated with
peroxidase (Cell Signaling Technology, Beverly, MA, 1:2000). Bands were
visualized with ECL detection kit (Amersham Pharmacia, Buckinghamshire, UK).
Morphometric analysis for neurite outgrowth of Nurr1-induced
TH cells
The length of neurites from TH-immunoreactive cells was measured as previously
described (Kim, J. Y. et al., 2003). Briefly, TH+ cells from randomly selected areas
of at least five cultures from three independent experiments were photographed, and
morphometric analysis was carried out using an Axiovert phase-contrast microscope
equipped with an Axiocam digital camera system and Axiovision image analyzer
(Carl Zeiss, Zena, Germany). The length of a neurite was defined as the distance
from the soma to the tip of the branch. The total neurite outgrowth was defined as
the combined length of all neurites per cell.
Quantification of DA release
DA release in the medium conditioned by the differentiated precursor cells was
detected using reverse-phase HPLC. Differentiated precursor cells in 24-well plates
were incubated in 500 l N2 plus AA medium or in the same medium supplemented
with 56 mM KCl (evoked) for 15 minutes. The media were then collected and
stabilized with 0.1 N perchloric acid containing 0.1 mM EDTA and analyzed for
DA. The method used for the alumina extraction for dopamine analysis is generally
that of Anton and Sayre (Anton and Sayre, 1962). Samples (40 l) were injected
with a Rheodyne injector and separated with a reverse-phase -Bondapak C18
column (1503.0 mm, Eicom, Japan) maintained at 32°C with a column heater
(Waters, Cotland, NY). The mobile phase consisted of 0.05 M citric acid, 0.05 M
disodium phosphate (pH 3.1), 3.2 mM 1-octanesulfonic acid (sodium salt), 0.3 mM
EDTA and 12% methanol which was pumped at a flow rate of 0.5 ml/minute using
a Waters solvent delivery system. Electroactive compounds were analyzed at +750
mV using an analytical cell and an amperometric detector (Eicom, Model ECD-
300, Japan). DA levels were calculated using external DA standard injected
immediately before and after each experiment.
DA uptake assay
DA uptake assays were conducted according to the methods previously described
with minor modifications (Lee et al., 2000). Cells were washed with PBS and
incubated with 50 nM [3H]DA in PBS (5 Ci/mmol, Amersham, Buckinghamshire,
UK) with or without 10 M nomifensine (RBI, Natick, MA), a dopamine
transporter (DAT) blocker, to determine the level of nonspecific uptake. After
incubation for 10 minutes at 37°C, the uptake reactions were terminated by
aspiration of the reaction solution and washing twice with ice-cold PBS. Cells were
lysed in 0.5 M NaOH and the radioactivity was measured by liquid scintillation
counting (MicroBeta® TriLux ver. 4.4, Wallac, Turku, Finland). The specific DA-
uptake level was calculated by subtracting nonspecific uptake (with nomifensine)
from uptake value without nomifensine.
Electrophysiology
Electrophysiological properties of Nurr1-expressing cells were examined using the
whole-cell recording configuration obtained by the conventional ‘dialysed’ whole-
cell patch-clamp technique. Precursor cells isolated from E14 rat cortices were
cultured on 12 mm diameter coverslips and infected with the retroviral constructs
of pNurr1-IRES-eGFP plus pCL-Mash1 (or pCL-LacZ for a control) as described
above. After 10 days of in vitro differentiation, individual Nurr1-expressing cells,
identified by GFP expression under a GFP-filtered microscope, were selected for
the electrophysiological analysis. Patch electrodes were fabricated from a
borosilicate glass capillary (Sutter Instrument, San Rafael, CA) by using a vertical
micropipette puller (Narishige, Tokyo, Japan). The patch electrodes were fire-
polished on a microforge (Narighige) and had resistances of 2-4 M when filled
with the internal solution described below. The cell membrane capacitance and
series resistance were compensated (typically >80%) electronically using a patch-
clamp amplifier (Axopatch-200A; Axon Instruments, Foster City, CA). Current
protocol generation and data acquisition were performed using pClamp 8.2 software
on an IBM computer equipped with an analog-to-digital converter (Digidata 1322A;
Axon Instruments). Voltage traces were filtered at 5 KHz by using the four-pole
Bessel filter in the clamp amplifier and stored on the computer hard drive for
subsequent analyses. All experiments were performed at room temperature (21-
24°C). For recording of membrane potential in current clamp mode, the patch
pipette solution contained 134 M KCl, 1.2 M MgCl2, 1 M MgATP, 0.1 M
Na2GTP, 10 M EGTA, 14 M glucose and 10.5 M HEPES (pH adjusted to 7.2
with KOH). The bath solution contained 134 M NaCl, 5 M KCl, 2.5 M CaCl2,
1.2 M MgCl2, 14 M glucose and 10.5 M HEPES (pH adjusted to 7.4 with
NaOH).
BrdU-incorporation assay
The effect of Ngn1 on cell proliferation was determined using BrdU assay and
compared with the effect of the bFGF-signaling blockers SU5402 (20 M,
Calbiochem) and PD98059 (25 M, Calbiochem). Cells were treated with 10 M
BrdU (Roche, Basel, Switzerland) and then examined by immunocytochemistry
with anti-BrdU antibody.
Promoter Assay
The luciferase reporter vectors pTH6.0-GL3 and p(NL3)4-GL3 have been
constructed by engineering the 6.0 kb upstream sequences of the rat TH gene and
four copies of NL3 sequence respectively into pGL3® (Promega) bacterial luciferase
plasmid (Kim, K. S. et al., 2003). PCR-amplified coding fragments of Nurr1,
Mash1, Ngn1, Ngn2, NeuroD, the bHLH mutants and the chimeric-bHLHs were
cloned into the multiple cloning sites of pEF6/V5-HisA® (Invitrogen) to generate
the pEF1-based expression constructs in which the cloned gene is designed to be
expressed under the control of EF1 promoter. Plasmids for transfection were
prepared using Qiagen columns (Qiagen, Santa Clarita, CA). The proliferating
precursor cells cultured in 24-well plates as described above were transfected using
Lipofectamine 2000® (Invitrogen) with a reporter construct (0.05 pmole), pEF1-
gal (0.05 pmole, to correct the difference of transfection efficiencies), pEF1-
Nurr1 (0.1 pmole) and pEF1-bHLH (or pEF1-eGFP as a negative control for the
bHLH effect, 0.1 pmole). 48 hours later, transfected cells were examined with a
luciferase assay kit (BD Bioscience Pharmingen, Franklin Lakes, NJ) and measured
with a luminometer (Orion I microplate luminometer, Berthold detection system,
Oak Ridge, TN). To correct for differences in transfection efficiencies among
different DNA precipitates, luciferase activity was normalized to that of -
galactosidase activity estimated by ELISA reader (model 550, BioRad).
Cell counting and statistic analysis
Cell counting was performed in microscopic fields, using an eye-piece grid at a final
magnification of 200 or 400. Five to ten microscopic fields were randomly
chosen in each well and three to six culture wells were analyzed in each experiment.
Data are expressed as mean ± s.e.m. Statistical comparisons were made by ANOVA
with Tukey post-hoc analysis (SPSS 11.0; SPSS, Chicago, IL) when more than two
groups were involved.
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